AB Science said it received a notice of allowance from the European Patent Office for a patent covering the use…
Andrea Lobo, PhD
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She has authored multiple research papers in peer-reviewed journals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
A Nigerian hematologist will pursue a PhD in health policy at the University of Tennessee Health Science Center to help…
Sigma Gamma Rho Sorority, a national collegiate women’s organization, has committed to raising $2 million by 2028 to…
Reproductive health issues were found to be common after a stem cell transplant among young people with sickle cell…
The use of eculizumab, an immunosuppressive medication approved for several autoimmune diseases, was found to be safe and effective for…
Emmaus Life Sciences, which markets Endari (L-glutamine) for sickle cell disease (SCD), has announced that it is complying…
The probability of developing organ and tissue damage — including in the lungs, kidneys, or eyes — increases as teenagers…
The Bahrain Oncology Center now is among the first in the world to offer Casgevy (exagamglogene autotemcel), an approved…
Bluebird Bio has announced it’s completed collecting cells from the first sickle cell disease (SCD) patient receiving the…
Having male adolescents with sickle cell disease (SCD) undergo fertility testing by semen analysis may not be feasible if…